Use of the Xpert Breast Cancer STRAT4 for Biomarker Evaluation in Tissue Processed in a Developing Country

OBJECTIVES: Breast cancer immunohistochemistry (IHC) biomarker testing is limited in low-resource settings, and an alternative solution is needed. A point-of-care mRNA STRAT4 breast cancer assay for ESR1, PGR, ERBB2, and MKi67, for use on the GeneXpert platform, has been recently validated on tissue...

Descripción completa

Detalles Bibliográficos
Autores principales: Mugabe, Marcellin, Ho, Kenneth E, Ruhangaza, Deo, Milner, Dan, Rugwizangoga, Belson, Chu, Victor C, Wu, Natalie C, Rizo, Annaliza, Weidler, Jodi M, Wong, Wendy, Bates, Michael, Brock, Jane E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512210/
https://www.ncbi.nlm.nih.gov/pubmed/34050358
http://dx.doi.org/10.1093/ajcp/aqab016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8512210/
https://www.ncbi.nlm.nih.gov/pubmed/34050358
http://dx.doi.org/10.1093/ajcp/aqab016

Ejemplares similares